ArticleInfectious diseases and therapy2024

A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies.

Norman Moullan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.